Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 14, 2025; 31(10): 102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Table 2 Survival data of 32 cases of oesophageal gastrointestinal stromal tumour, n (%)
Parameter | Variable |
Treatment | |
Imatinib | 2 (6.3) |
Wait and see | 30 (93.7) |
Follow-up time | |
Mean (mean ± SD) | 64.69 ± 33.13 |
Median (month, range) | 65.50 (37.75-93.00) |
Survival data | |
Recurrence | 3 |
GISTs-related deaths | 0 |
Survival rates (%) | |
1-/3-/5-year OS | 100/100/100 |
1-/3-/5-year DFS | 100/90.6/90.6 |
- Citation: Xu EP, Qi ZP, Zhang JW, Li B, Ren Z, Cai MY, Cai SL, Lv ZT, Chen ZH, Liu JY, Zhong YS, Zhou PH, Shi Q. Endoscopic treatment outcome of oesophageal gastrointestinal stromal tumours. World J Gastroenterol 2025; 31(10): 102393
- URL: https://www.wjgnet.com/1007-9327/full/v31/i10/102393.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i10.102393